Similar articles for PMID: 23151137

Year	Number of Results
2003	1
2006	2
2007	1
2008	3
2009	2
2010	8
2011	12
2012	16
2013	18
2014	12
2015	7
2016	11
2017	8
2018	14
2019	10
2020	19
2021	28
2022	23
2023	12
2024	0

1

Cullin-RING Ligases as attractive anti-cancer targets.

Zhao Y, Sun Y. Zhao Y, et al. Curr Pharm Des. 2013;19(18):3215-25. doi: 10.2174/13816128113199990300. Curr Pharm Des. 2013. PMID: 23151137 Free PMC article. Review.

2

Targeting NEDD8-activated cullin-RING ligases for the treatment of cancer.

Soucy TA, Smith PG, Rolfe M. Soucy TA, et al. Clin Cancer Res. 2009 Jun 15;15(12):3912-6. doi: 10.1158/1078-0432.CCR-09-0343. Epub 2009 Jun 9. Clin Cancer Res. 2009. PMID: 19509147

3

Targeting Neddylation pathways to inactivate cullin-RING ligases for anticancer therapy.

Zhao Y, Morgan MA, Sun Y. Zhao Y, et al. Antioxid Redox Signal. 2014 Dec 10;21(17):2383-400. doi: 10.1089/ars.2013.5795. Epub 2014 Feb 20. Antioxid Redox Signal. 2014. PMID: 24410571 Free PMC article. Review.

4

Targeting the neddylation pathway in cells as a potential therapeutic approach for diseases.

Ying J, Zhang M, Qiu X, Lu Y. Ying J, et al. Cancer Chemother Pharmacol. 2018 May;81(5):797-808. doi: 10.1007/s00280-018-3541-8. Epub 2018 Feb 15. Cancer Chemother Pharmacol. 2018. PMID: 29450620 Review.

5

Introduction.

Sun Y. Sun Y. Adv Exp Med Biol. 2020;1217:1-8. doi: 10.1007/978-981-15-1025-0_1. Adv Exp Med Biol. 2020. PMID: 31898218

6

[Targeting Cullin-RING E3 ligases for anti-cancer therapy: efforts on drug discovery].

Yu Q, Xiong X, Sun Y. Yu Q, et al. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 May 25;49(1):1-19. doi: 10.3785/j.issn.1008-9292.2020.02.21. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020. PMID: 32621419 Free PMC article. Review. Chinese.

7

Targeting Protein Neddylation to Inactivate Cullin-RING Ligases by Gossypol: A Lucky Hit or a New Start?

Yu Q, Sun Y. Yu Q, et al. Drug Des Devel Ther. 2021 Jan 6;15:1-8. doi: 10.2147/DDDT.S286373. eCollection 2021. Drug Des Devel Ther. 2021. PMID: 33442232 Free PMC article. Review.

8

Cullin 5-RING E3 ubiquitin ligases, new therapeutic targets?

Lamsoul I, Uttenweiler-Joseph S, Moog-Lutz C, Lutz PG. Lamsoul I, et al. Biochimie. 2016 Mar;122:339-47. doi: 10.1016/j.biochi.2015.08.003. Epub 2015 Aug 4. Biochimie. 2016. PMID: 26253693 Free article. Review.

9

Cullin-RING Ligases as Promising Targets for Gastric Carcinoma Treatment.

Song Q, Feng S, Peng W, Li A, Ma T, Yu B, Liu HM. Song Q, et al. Pharmacol Res. 2021 Aug;170:105493. doi: 10.1016/j.phrs.2021.105493. Epub 2021 Feb 15. Pharmacol Res. 2021. PMID: 33600940 Review.

10

A Destiny for Degradation: Interplay between Cullin-RING E3 Ligases and Autophagy.

Lu G, Wang L, Zhou J, Liu W, Shen HM. Lu G, et al. Trends Cell Biol. 2021 Jun;31(6):432-444. doi: 10.1016/j.tcb.2021.01.005. Epub 2021 Feb 8. Trends Cell Biol. 2021. PMID: 33573849 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

192 results

Results by year